LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis
about
sameAs
Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesisHepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver diseaseDynamic populations of dendritic cell-specific ICAM-3 grabbing nonintegrin-positive immature dendritic cells and liver/lymph node-specific ICAM-3 grabbing nonintegrin-positive endothelial cells in the outer zones of the paracortex of human lymph nodUp-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumorsLymph vessels: the forgotten second circulation in health and diseaseSize Matters: Molecular Weight Specificity of Hyaluronan Effects in Cell BiologyNovel molecular pathways in Gorham disease: implications for treatmentThe IL1 -S100A13 Heterotetrameric Complex Structure: A COMPONENT IN THE NON-CLASSICAL PATHWAY FOR INTERLEUKIN 1 SECRETIONThe Role of Lymphatic Endothelial Cells in Liver Injury and Tumor DevelopmentHuman hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivoFoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasisHOXA13 Is essential for placental vascular patterning and labyrinth endothelial specificationMolecular cloning and functional expression of the rat 175-kDa hyaluronan receptor for endocytosisThy-1 is expressed in hepatic myofibroblasts and not oval cells in stem cell-mediated liver regeneration.Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers.Mapping the extracellular and membrane proteome associated with the vasculature and the stroma in the embryoLymphatic vessels assessment in feline mammary tumours.Lymphatic marker podoplanin/D2-40 in human advanced cirrhotic liver--re-evaluations of microlymphatic abnormalitiesAngiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration.Unique cell type-specific junctional complexes in vascular endothelium of human and rat liver sinusoids.Molecular characterization of lymphatic endothelial cells.Novel expression and characterization of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1) by conjunctival cells.Gastrointestinal lymphatics in health and diseaseHyaluronan as an immune regulator in human diseases.Novel discovery of LYVE-1 expression in the hyaloid vascular systemCharacterization of Prox1 and VEGFR-3 expression and lymphatic phenotype in normal organs of mice lacking p50 subunit of NF-κB.Radiation-induced impairment in lung lymphatic vasculatureMouse lymphatic endothelial cell targeted probes: anti-LYVE-1 antibody-based magnetic nanoparticles.Generation and characterization of novel stromal specific antibodies.Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors.Mapping the distinctive populations of lymphatic endothelial cells in different zones of human lymph nodes.Proinflammatory signals and the loss of lymphatic vessel hyaluronan receptor-1 (LYVE-1) in the early pathogenesis of laminin alpha2-deficient skeletal muscle.Lack of lymphangiogenesis during breast carcinogenesisThe use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status.Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.Lymphatics at the crossroads of angiogenesis and lymphangiogenesis.Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic AdenocarcinomaMacrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors.Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugatesEfficient and robust differentiation of endothelial cells from human induced pluripotent stem cells via lineage control with VEGF and cyclic AMP.
P2860
Q24669710-5F146F39-ACD0-4528-ABD1-17CE8F9FFBD9Q24669792-692AD24C-8A4C-41CC-8064-F2728A532A16Q24672274-01117E9A-31E8-4E33-92CE-997DEB20B15AQ24675750-4E32F66C-D740-4787-8402-2F1669FD4132Q26750211-A112E41D-13AC-4FBC-9BC6-163C1E385B8DQ26786063-68A111E5-F4DB-434A-B5AA-05D79C9BB50AQ27005629-292A70F6-424F-4737-A035-62027C2486C9Q27666745-A079667C-B9FE-4AF8-BA7A-BC40EBA4B938Q28074554-EB7AA87F-12D4-4BEF-8FB2-C8146ADB7C40Q28265835-19003B6A-B6E3-4A62-8E69-FC4BB2FC8151Q28285131-C6DC03AE-1A07-41B5-95EA-E997113CF402Q28513845-CF6FFFA5-6906-4324-8A4F-BEFEC4C1E65BQ28579566-17F65138-8A81-4729-BCBB-7BC1330309C4Q30480301-D64130B2-9987-4511-9368-B323EE2C2EA8Q30542073-E3007F4E-35FB-4141-8DD2-0D0E5D40C9AFQ30542280-7E165BF2-04BA-42D9-B2EE-7D2A3D22F523Q33269181-32A9571B-8D10-4C4A-A183-75AD33357F0AQ33741078-E6AEF70D-A117-4FB8-8EA4-020AC6749D2BQ34130424-F22BEEB2-7551-43DB-BECE-B1ECD8CACC45Q34235112-7AC35329-08EA-4661-B596-A64D4614ECECQ34415420-64EDFF39-BB62-414E-B891-FFB38FD6E463Q34441485-06F23C64-9782-4097-81A4-39105D2C4844Q34519124-26528DA3-F4C2-46AA-A4A7-C96F36D15761Q34636380-B584F131-BBFD-4005-A4A5-E907D69AEB02Q34662126-CEC9FDA2-A1F6-4159-A62E-50576BD2C36CQ34681080-A50E0911-6114-43F4-8C6C-2992D39EAD53Q34707886-9F3F8FE4-B070-4F09-B601-669A31519F6FQ34789226-4FFE48FE-C0E6-459C-A214-C02E7104F768Q35058582-5C9F2234-A529-454C-90BB-95E4BDEC0B36Q35103259-10C9C49B-375D-4082-ACEA-509E34057227Q35147860-308C73BB-0225-45F2-8FE0-C90028E2E0F5Q35440708-266C099A-2B53-4253-838D-9892BF60BE33Q35587730-7CDC9A55-BEE4-4617-8500-30776C2D2AF6Q35588719-A4FE5333-D6BB-4469-A35B-B4FD7D5A2633Q35791518-CCFA3EC3-B0DF-4B3D-9867-591A06BB7F8EQ35805972-B7B29028-066E-479F-A3C6-CA955C370D3CQ35964357-3AFC4952-29AB-4435-952A-187B7A9531D7Q36198192-DB338916-5AE0-40FA-BD92-F3B4E2791C61Q36204729-E3FCD2AE-3E4F-4570-8C5A-9345BFDC8542Q36306140-6409CE85-B28A-47AA-AFBF-332786AFA106
P2860
LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
LYVE-1 is not restricted to th ...... man liver cancer and cirrhosis
@ast
LYVE-1 is not restricted to th ...... man liver cancer and cirrhosis
@en
LYVE-1 is not restricted to th ...... man liver cancer and cirrhosis
@nl
type
label
LYVE-1 is not restricted to th ...... man liver cancer and cirrhosis
@ast
LYVE-1 is not restricted to th ...... man liver cancer and cirrhosis
@en
LYVE-1 is not restricted to th ...... man liver cancer and cirrhosis
@nl
prefLabel
LYVE-1 is not restricted to th ...... man liver cancer and cirrhosis
@ast
LYVE-1 is not restricted to th ...... man liver cancer and cirrhosis
@en
LYVE-1 is not restricted to th ...... man liver cancer and cirrhosis
@nl
P2093
P3181
P1433
P1476
LYVE-1 is not restricted to th ...... man liver cancer and cirrhosis
@en
P2093
C Mouta Carreira
E di Tomaso
S I Tomarev
S M Nasser
T P Padera
P304
P3181
P407
P577
2001-11-15T00:00:00Z